baber/WOPTO huggingface dataset:
Patent MY-134105-A (MY)
Title: Polyester film for releasing a polarizing plate
Inventor: MIZUTANI KEI
IPC: C09J7/29
Filed: 2002-01-04
Abstract: A FILM FOR RELEASING A POLARIZING PLATE, WHICH HAS EXCELLENT TRANSPARENCY, SILICONE ADHESION AND PROCESSING WORK EFFICIENCY, AND A SMALL ORIENTATION ANGLE, CONTAINS LITTLE OPTICAL FORIEGN MATTER AND IS HARDLY SCRATCHED. @THIS FILM COMPRISES A COEXTRUDED POLYESTER FILM COMPRISING AT LEAST TWO LAYERS AND A SILICONE ADHESIVE LAYER. THE COEXTRUDED POLYESTER FILM HAS A HAZE VAUE OF 4OR LESS AND AN ORIENTATION ANGLE OF 10?C OR LESS AND CONTAINS 5 OR LESS FLYSPECKS HAVING A LONG DIAMETER OF 90 UM OR MORE PER 0.3 M2.
Patent MY-135822-A (MY)
Title: Induction-heated reactors for gas phase catalyzed reactions
Inventor: BLACKWELL BENNY E
IPC: B01J35/02
Filed: 2003-03-13
Abstract: ELEVATE TEMPERATURE, GAS-PHASE, CATALYZED PROCESSES FOR PREPARING HCN IN WHICH INDUCTION HEATING IS USED AS A SOURCE OF ENERGY, AND NOVEL APPARATUS FOR CARRYING OUT SAID PROCESSES.FIG.1
Patent MY-133527-A (MY)
Title: Isoquinoline derivatives
Inventor: CESURA ANDREA
IPC: C07D405/06
Filed: 2003-04-25
Abstract: THIS INVENTION RELATES TO ISOQUINOLINO DERIVATIVES OF THE GENERAL FORMULA WHEREIN Y IS >C=O OR -CH2-, Z IS >C=O OR -CH2-, AND R1, R2 AND M ARE AS DEFINED IN THE SPECIFICATION, AS WELL AS THEIR PHARMACEUTICALLY ACCEPTABLE SALTS. THE INVENTION FURTHER RELATES TO MEDICAMENTS CONTAINING THESE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AS WELL AS THEIR USE FOR PREPARATION OF MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF DISEASES IN WHICH MAO-B INHIBITORS MIGHT BE BENEFICIAL.
Patent MY-135100-A (MY)
Title: Method and apparatus for making pallets from coconut shells
Inventor: HIROMI WATAYA
IPC: B65D19/00
Filed: 2003-08-29
Abstract: DISCLOSED IS AN IMPROVEMENT IN OR RELATING TO THE METHOD OF MAKING PALLETS OF PLANT FIBERS SUCH AS COCONUT FIBERS OR JUTE, WHICH METHOD ASSURES THAT THE PALLET MATERIAL BE HEATED EVENLY, AND THAT PALLETS BE MADE EASILY AND QUICKLY.UNWOVEN FABRIC OF PLANT FIBERS RANDOMLY TANGLED IS IMPREGNATED WITH RESIN. A SHEET OF RESIN-IMPREGNATED FELT IS SANDWICHED BETWEEN UPPER AND LOWER METAL MOLD HALVES, AND THE SO SANDWICHED MATERIAL IS HEATED BY HOT AIR FLOWING FROM ONE TO OTHER METAL MOLD HALF TO SHAPE THE SANDWICHED MATERIAL INTO A PALLET.THE HEATED AIR IS CIRCULATED FROM A HEATED AIR GENERATOR BACK TO THE SAME THROUGH THE UPPER AND LOWER METAL MOLD HALVES.FIGURE 1
Patent MY-148297-A (MY)
Title: Process for modifying drug crystal formation
Inventor: PFEFFER SABINE
IPC: A61K9/14
Filed: 2004-01-19
Abstract: A PROCESS FOR MODIFYING THE CRYSTAL HABIT OF ACICULAR DRUG SUBSTANCES, CRYSTALS OBTAINED BY SUCH A PROCESS, AND PARTICULAR CRYSTAL FORMS OR MODIFICATIONS OF MYCOPHENOLIC ACID OR MYCOPHENOLATE SODIUM ARE PROVIDED, AS WELL AS PHARMACEUTICAL COMPOSITIONS COMPRISING THE CRYSTALS, METHOD OF TREATMENT AND USES THEREOF.
Patent MY-137005-A (MY)
Title: Electromagnetic fuel injection valve
Inventor: AKABANE AKIRA
IPC: F02M51/00
Filed: 2004-03-23
Abstract: AN ELECTROMAGNETIC FUEL INJECTION VALVE (I) IS PROVIDED THAT INCLUDES A FIXED CORE (5) MADE OF A HIGH HARDNESS FERRITE MAGNETIC MATERIAL, AND A MOVABLE CORE (12) THAT HAS FIXED THERETO BY PRESS-FITTING A STOPPER ELEMENT (14) THAT IS NONMAGNETIC OR IS MORE WEAKLY MAGNETIC THAN THE MOVABLE CORE (12), THE STOPPER ELEMENT (14) ABUTTING DIRECTLY AGAINST THE FIXED CORE (5) SO AS TO MAINTAIN AN AIR GAP (G) BETWEEN THE TWO CORES (5) AND (12) WHEN A COIL (30) IS ENERGIZED. IN THIS WAY, HIGH ABRASION RESISTANCE AND RESPONSIVENESS CAN BE IMPARTED TO THE FIXED CORE AND THE MOVABLE CORE WITHOUT SUBJECTING THE TWO CORES TO A TROUBLESOME ABRASION RESISTANCE TREATMENT TO PROVIDE A PLATING LAYER, ETC., AND WITHOUT PROVIDING A VALVE BODY STOPPER PLATE, THEREBY CONTRIBUTING TO A REDUCTION IN THE COST OF THE ELECTROMAGNETIC FUEL INJECTION VALVE.
Patent MY-137959-A (MY)
Title: High purity electrolytic sulfonic acid solutions
Inventor: MARTYAK NICHOLAS M
IPC: H01M10/26
Filed: 2004-05-10
Abstract: DISCLOSED IS A SOLUTION FOR AN ELECTROCHEMICAL PROCESS, THE SOLUTION CONTAINING A SULFONIC ACID AND HAVING A LOW CONCENTRATION OF SULFUR COMPOUNDS, EITHER LOW OR HIGH VALENCE, THAT ARE SUSCEPTIBLE TO REDUCTION AND WHICH IS INTENDED FOR USE IN ELECTRODEPOSITION, BATTERIES, CONDUCTIVE POLYMERS AND DESCALING PROCESSES.
Patent MY-147639-A (MY)
Title: Coated tablet formulation and method
Inventor: DESAI DIVYAKANT S
IPC: A61K9/24
Filed: 2005-05-26
Abstract: A COATED TABLET FORMULATION IS PROVIDED WHICH INCLUDES A MEDICAMENT SUCH AS THE DPP4-INHIBITOR, SAXAGLIPITIN WHICH IS SUBJECT TO INTRA-MOLECULAR CYCLIZATION, WHICH FORMULATION INCLUDES A TABLET CORE CONTAINING A ONE OR MORE FILLERS. AND OTHER CONVENTIONAL EXCIPIENTS, WHICH TABLET CORE INCLUDES A COATING THEREON WHICH MAY INCLUDE TWO OR MORE LAYERS, AT LEAST ONE LAYER OF WHICH IS AN INNER SEAL COAT LAYER WHICH IS FORMED OF ONE OR MORE COATING POLYMERS, A SECOND LAYER OF WHICH IS FORMED OF MEDICAMENT WHICH IS THE DPP4- INHIBITOR AND ONE OR MORE COATING POLYMERS, AND AN OPTIONAL, BUT PREFERABLE THIRD OUTER PROTECTIVE LAYER WHICH IS FORMED OF ONE OR MORE COATING POLYMERS. A METHOD FOR FORMING THE COATED TABLET IS ALSO PROVIDED.
Patent MY-139156-A (MY)
Title: Power led package
Inventor: DU SHAWN X
Filed: 2005-09-23
Abstract: OF THE DISCLOSURE LU A CHIP PACKAOC (10, 101@ 110: NO), FIRST AND SECOND ELEC-MCAL POWERBUSES 5 C (34, 14': 16, 16-T 114, 116, 114, 216) ARE EACH FORMED OF AN CLECTTICAL CONDUCTOR HAVING A CHIP BONDING PORTION (20, 22, IM 122: 220T 222) AND A LEAD PORTION (26, 26'., -)S, 28-T 126, 128: 2261 228) EXICNDINTZ AWAY FTOM THE CHIP BONDING PORTION. THE CHIP BONDING PORTIONS OF THE FIRST AND SECOND ELECTRICAL POWER BUSES HAVE EDOES (32, 34, 132, 134, 232, 234) SPACED APART FROM ONE ANOTHER TO DEFINE AN EXTENDED ELECTRICAL 10 ISOLATION GAP (40, 140, 240). A PLURALITY OF CHIPS (42, 44, 46@ 142, 143: 144, 145, 346, 147, 14S7 242) STRADDLE THE EXIENDED ELECTRICAL ISOLATION GAP AND ARE ELECTRICALL'Y CORMECTED WITH THE FIRST AND SECOND EICCFFICAL POIATT BUSES TO JECEIVE ELECTRICAL PCWEY FROM THE FIRST AND SECOND EL@CTRICAL POWER BUSES. 1 5
Patent MY-143798-A (MY)
Title: Thermoplastic molding materials based on polyesters and styrene copolymers
Inventor: MARTIN WEBER DR
IPC: C08L67/02
Filed: 2006-07-31
Abstract: 46 THERMOPLASTIC MOLDING COMPOSITIONS BASED ON POLYESTERS AND ON STYRENE COPOLYMERS W 3 ABSTRACT IPP 5 THERMOPLASTIC MOLDING COMPOSITIONS. COMPRISING A) FROM 1 0 TO 97.5BY WEIGHT OF AT LEAST ONE THERMOPLASTIC POLYESTER A, B) FROM 1 TO 97.5BY WEIGHT OF AT LEAST ONE GRAFT POLYMER B COMPOSED OF 1 0 BL) FROM 40 TO 80BY WEIGHT OF A GRAFT BASE COMPOSED OF AN ELASTORNERIC POLYMER B1 BASED ON ALKYL ACRYLATES HAVING FROM 1 TO 8 CARBON ATOMS IN THE ALKYL RADICAL, ON ETHYLENE/PROPYLENE, ON DIENES, OR ON SILOXANES, AND WITH A GLASS TRANSITION TEMPERATURE BELOW DOC, 1 5 B2) FROM 20 TO 60BY WEIGHT OF A GRAFT B2 COMPOSED OF B2L) FROM 60 TO 95BY WEIGHT OF STYRENE OR OF SUBSTITUTED STYRENES B21 OF THE GENERAL FORMULA 1 20 R-C=CH2 (R), WHERE R IS A CI-8-ALKYL RADICAL OR HYDROGEN AND R1 IS A C1.8-ALKYL RADICAL AND N, IS 1, 2, OR 3, OR A MIXTURE OF THESE, AND 25 B22) FROM 5 TO 40BY WEIGHT OF AT LEAST ONE UNSATURATED NITRILE 822. C) FROM 1 TO 97.5BY WEIGHT OF AT LEAST ONE THERMOPLASTIC COPOLYMER C COMPOSED OF 30 CL) FROM 60 TO 85BY WEIGHT OF STYRENE OR OF SUBSTITUTED STYRENES C1 OF THE GENERAL FORMULA 1. OR A MIXTURE THEREOF, AND C2) FROM 1 5 TO 40BY WEIGHT OF AT LEAST ONE UNSATURATED NITRILE C2. 35 D) FROM 0.5 TO 50BY WEIGHT OF AT LEAST ONE COPOLYMER D, OBTAINABLE VIA REACTION OF D1) FROM 5 TO 95BY WEIGHT OF AT LEAST ONE THERMOPLASTIC METHACRYLATE POLYMER
Patent MY-148222-A (MY)
Title: Biphasic calcium phosphate scaffold containing magnesium and a preparation method thereof
Inventor: SOPYAN ASSOC PROF DR IIS
IPC: A61F2/28
Filed: 2008-11-14
Abstract: THIS INVENTION RELATES TO A POLYMERIC SPONGE METHOD IN PRODUCING POROUS BIPHASIC CALCIUM PHOSPHATE CERAMICS CONTAINING MAGNESIUM FOR HIGH PERFORMANCE BIOACTIVE BONE SCAFFOLD APPLICATIONS. POLYMERIC SPONGE METHOD IS ABLE TO PROVIDE A PROPER PORE SIZE DISTRIBUTION, AS OSTEOCONDUCTION REQUIRES. THIS IS CHARACTERIZED BY THE EXISTENCE OF MICRO/MESO/MACROPORES WITH ADEQUATE DEGREE OF INTERCONNECTION. CALCIUM PHOSPHATE IS AN INTERESTING MATERIAL FOR BONE IMPLANT APPLICATIONS, AS IT SHOWS BIOCOMPATIBILITY AND BIOACTIVITY TO TISSUE BONE. AMONG CALCIUM PHOSPHATE- BASED MATERIALS, BIPHASIC CALCIUM PHOSPHATE (BCP), A MIXTURE OF NON-RESORBABLE HYDROXYAPATITE (HA) AND RESORBABLE TRICALCIUM PHOSPHATE (TCP), HAS SHOWN TO POSSESS UNIQUE CHARACTERISTICS APPROPRIATE FOR BONE REPLACEMENT. DOPING OF MAGNESIUM IONS INTO BCP WILL BRING BIOLOGICAL IMPROVEMENT. MAGNESIUM ION WAS FOUND TO CAUSE THE ACCELERATION OF NUCLEATION KINETICS OF BONE MINERALS. THEREFORE, THE INCORPORATION OF MAGNESIUM IONS INTO THE CALCIUM PHOSPHATE STRUCTURE IS OF GREAT INTEREST FOR THE DEVELOPMENT OF ARTIFICIAL BONE.
Patent MY-152573-A (MY)
Title: Method to determine and visualize line-of-sight
Inventor: KADIM ZULAIKHA
IPC: G06T15/00
Filed: 2009-06-10
Abstract: A METHOD TO DETERMINE AND VISUALIZE HUMAN LINE-OF-SIGHT FROM A SEQUENCE OF IMAGE IS DESCRIBED. FIRST, A MOTION BLOB IS DETECTED FROM THE IMAGE (20). THEN, THE HUMAN LOCATION FROM THE MOTION BLOB IS DETECTED AND TRACKED (30) BY ENCLOSING A RECTANGLE AROUND THE BOUNDARIES OF THE BLOB. THE FACE REGION IS THEN DETECTED FROM THE BLOB (40). AFTER THAT, THE GAZE DIRECTION FROM THE BLOB IS DETECTED (50). LATER, THE LINE-OF-SIGHT IS VISUALIZED FROM THE FACE REGION TOWARDS A DIRECTION DETERMINED BY GAZE DIRECTION (70). THE HUMAN BLOB AND VISUALIZATION IS REPRESENTED IN A 3-DIMENSIONAL CUBE CORRESPONDING TO THE SEQUENCE OF IMAGE.
Patent MY-144589-A (MY)
Title: A shopping system and method
Inventor: MEBRUER ROBERT
IPC: G06Q30/00
Filed: 2005-06-08
Abstract: A SHOPPING SYSTEM AND METHOD IS DISCLOSED FOR PROVIDING AN INDUCEMENT TO A SHOPPER TO PURCHASE PRODUCTS. THE INDUCEMENT MAY BE BY WAY OF A SHOPPING LIST OR A COUPON PROVIDING BENEFITS WHEN PRODUCTS ARE PURCHASED. A CARD READER (105, 515) IS PROVIDED FOR READING A CUSTOMER'S CARD TO IDENTIFY THE CUSTOMER, AND PROCESSORS (P1, P2) ARE PROVIDED FOR CONTAINING DATABASES WHICH INCLUDE CUSTOMER INFORMATION SO THAT TARGETED OFFERS CAN BE MADE SPECIFIC TO A PARTICULAR CUSTOMER BY WAY OF A PRINTED SHOPPING LIST OR COUPON. A PRINTER (112) IS PROVIDED FOR PRINTING THE LIST AND A PRINTER (516) IS PROVIDED FOR PRINTING THE COUPONS. INFORMATION RELATING TO REDEEMED COUPONS IS ALSO OBTAINED SO THAT ORGANISATIONS MAKING OFFERS BY WAY OF THE COUPONS CAN BE BUILT FOR THE PROMOTIONAL OFFERS INCLUDED ON THE COUPONS.
Patent MY-153348-A (MY)
Title: Method for determining the optimal insertion force of a fastener press
Inventor: PATTON ROGER B
IPC: B23Q17/00
Filed: 2008-11-06
Abstract: FORCE DATA IS MONITORED BY A STRAIN GAUGE DURING A PREPARATORY SETUP OPERATION OF AN INSERTION PROCESS DURING WHICH A SAMPLE FASTENER IS INSTALLED INTO A HOST MATERIAL BY A FASTENER PRESS. MATHEMATICAL ALGORITHMS ARE UTILIZED TO DETERMINE AN OPTIMAL INSERTION FORCE, WHILE A PREDETERMINED INSERTION VELOCITY IS MAINTAINED THROUGHOUT THE INSTALLATION PROCESS REGARDLESS OF THE FORCE REQUIRED. WITH THE RAM VELOCITY HELD CONSTANT, THE INSERTION FORCE IS MEASURED DURING THE INSTALLATION PROCESS AND COMPARED TO THE ELAPSED TIME TO OBTAIN A FORCE SLOPE. A DATA POINT ON THE FORCE SLOPE WHICH CORRESPONDS TO THE POINT AT WHICH THE FORCE SLOPE ABRUPTLY INCREASES IS CAPTURED AND RECORDED AS THE OPTIMAL INSERTION FORCE. THIS OPTIMAL FORCE IS THEN USED BY THE PRESS FOR ALL FASTENERS/HOST-MATERIAL INSTALLATIONS OF THE SAMPLE TYPE.
Patent MY-154432-A (MY)
Title: Apparatus and method for positioning vehicle body parts
Inventor: TAKUJI IZUTANI
IPC: B62D65/00
Filed: 2008-04-14
Abstract: IN TEMPORARY WELDING OF VEHICLE BODIES, POSITIONING OF VEHICLE BODY PARTS IS CARRIED OUT HIGHLY ACCURATELY REGARDLESS OF THE TYPE OF VEHICLES, AND A REDUCTION IN EQUIPMENT INVESTMENT IS ACHIEVED BY REDUCING EQUIPMENTS REQUIRED FOR POSITIONING OR SPACE FOR STORING THE SAME. IN A TEMPORARY WELDING STEP OF A VEHICLE BODY (2), AN APPARATUS FOR POSITIONING VEHICLE BODY PARTS (10) FOR CARRYING OUT POSITIONING OF A ROOF PANEL (7) AND LEFT AND RIGHT SIDE MEMBERS (6, 6) HAS A PAIR OF FIRST CONTACT PORTIONS (18, 18) ATTACHED TO A POSITIONING BODY (12) VIA A RAIL PORTION (15) AND A SLIDE MEMBER (16) PROVIDED MOVABLY IN THE DIRECTION OF WIDTH OF THE VEHICLE, AND A PAIR OF SECOND CONTACT PORTIONS (19, 19) ATTACHED TO THE POSITIONING BODY (12) VIA THE RAIL PORTION (15) AND THE SLIDE MEMBER (16) PROVIDED MOVABLY IN THE DIRECTION OF WIDTH OF THE VEHICLE. THE FIRST CONTACT PORTIONS (18, 18) AND THE SECOND CONTACT PORTIONS (19, 19) BOTH CAN BE INSERTED INTO LEFT AND RIGHT GROOVE PORTIONS (8, 8) FORMED IN WELDING EDGE PORTIONS, RESPECTIVELY. THE FIRST CONTACT PORTIONS (18, 18) BOTH COME INTO CONTACT WITH THE INNER SIDE FACES (6A, 6A) OF THE SIDE MEMBERS (6, 6) BY BEING MOVED OUTWARDLY IN THE DIRECTION OF WIDTH OF THE VEHICLE IN A STATE OF BEING INSERTED, AND THE SECOND CONTACT PORTIONS (19, 19) BOTH COME INTO CONTACT WITH THE OUTER SIDE FACES (7A, 7A) OF THE ROOF PANEL (7) BY BEING MOVED INWARDLY IN THE DIRECTION OF WIDTH OF THE VEHICLE IN A STATE OF BEING INSERTED. THE CLEARANCE (W1) BETWEEN THESE FIRST CONTACT PORTIONS (18, 18) AND THE CLEARANCE (W1) BETWEEN THE SECOND CONTACT PORTIONS (19, 19) ARE BOTH VARIABLE, AND ARE CONTROLLED SO THAT THEY CAN BE EACH SET TO HAVE A PREDETERMINED DIMENSION DEPENDING ON THE TARGET TYPE OF VEHICLE. (FIGURES 6 AND 7)
Patent MY-152366-A (MY)
Title: Latency measurement in optical networks
Inventor: XIA TIEJUN J
IPC: H04B10/00
Filed: 2008-11-20
Abstract: A DEVICE FOR MEASURING OPTICAL LATENCY IN A TEST PATH INCLUDES AN OPTICAL SOURCE TO GENERATE AN OPTICAL SIGNAL. AN OPTICAL MODULATOR MODULATES THE OPTICAL SIGNAL BASED ON A MODULATION SIGNAL. AN OUTPUT PORT OUTPUTS THE MODULATED OPTICAL SIGNAL TO THE TEST PATH. AN INPUT PORT RECEIVES A RETURN OPTICAL SIGNAL FOLLOWING PROPAGATION THROUGH THE TEST PATH. LATENCY CALCULATING LOGIC CALCULATES THE OPTICAL LATENCY FOR THE TEST PATH BASED ON THE MODULATION SIGNAL AND THE RETURN OPTICAL SIGNAL.
Patent MY-147894-A (MY)
Title: Process for preparing intermediate compound for synthesizing an antiulcerant
Inventor: YEON KIM DONG
IPC: C07D403/06
Filed: 2008-11-20
Abstract: THE PRESENT INVENTION RELATES A NOVEL METHOD OF PREPARING AN INTERMEDIATE WHICH IS USEFUL FOR SYNTHESIZING AN ANTIULCERANT.THE PRESENT INVENTION PROVIDES A METHOD OF PREPARING AN INTERMEDIATE OF AN ANTIULCERANT WHICH CAN OBTAIN A HIGH PURITY COMPOUND IN HIGH YIELD, WITH REDUCED PRODUCTION COST/TIME AS COMPARED TO A CONVENTIONAL METHOD.
Patent MY-154232-A (MY)
Title: Cover type containing for flexible enclosures
Inventor: LIN CHE-WEN
IPC: A45C7/00
Filed: 2009-05-27
Abstract: A COVER-TYPE CONTAINING STRUCTURE FOR FLEXIBLE ENCLOSURES IS PROVIDED. THE STRUCTURE INCLUDES A FRONT COVER SHEET (1), AN EDGE OF WHICH IS PROVIDED WITH A COVER PIECE (11); A REAR COVER SHEET (2), AN EDGE OF WHICH IS PROVIDED WITH A COVER ASSEMBLY (21) CORRESPONDING TO THE COVER PIECE (11); A CONNECTION PORTION (12) WHICH IS PROVIDED BETWEEN THE FRONT COVER SHEET (1) AND THE REAR COVER SHEET (2) TO CONNECT THE TWO SHEETS; A FIRST JOINING EDGE (131) WHICH IS PROVIDED AT THE FRONT COVER SHEET (1), THE REAR COVER SHEET (2), BETWEEN THE FRONT COVER SHEET (1) AND THE REAR COVER SHEET (2). OR AT THE CONNECTION PORTION (12); AND A FLEXIBLE ENCLOSURE (3) WHICH INCLUDES A SECOND JOINING EDGE (331), THE FRONT COVER SHEET (1) AND THE FLEXIBLE ENCLOSURE (3) BEING FIXED BY ENGAGING THE FIRST JOINING EDGE (131) WITH THE CORRESPONDING SECOND JOINING EDGE (331); A CONTAINING SPACE BEING FORMED BETWEEN THE FRONT COVER SHEET (1) AND THE REAR COVER SHEET (2) TO CONTAIN THE FOLDED FLEXIBLE ENCLOSURE (3), AND THE FRONT COVER SHEET (2) AND THE REAR COVER SHEET (2) BEING CLOSED BY THE COVER PIECE (11) AND THE COVER ASSEMBLY (21); WHEREIN THE SECOND JOINING EDGE (331) IS PARTIALLY ENGAGED WITH THE FIRST JOINING EDGE (131) AND A CONTAINING PORT (301) IS FORMED AT A PLACE WHERE THE FIRST JOINING EDGE (131) IS NOT ENGAGED WITH THE SECOND JOINING EDGE (331); WHEN THE FLEXIBLE ENCLOSURE (3) IS UNFOLDED, THE REAR COVER SHEET (2) BEING PUT IN A CONTAINING SPACE BETWEEN THE FRONT COVER SHEET (1) AND THE FLEXIBLE ENCLOSURE (3) FROM THE CONTAINING PORT (301), WHEREAS, WHEN THE FOLDED FLEXIBLE ENCLOSURE (3) IS TO BE CONTAINED IN THE CONTAINING SPACE, THE REAR COVER SHEET (2) BEING TAKEN OUT OF THE CONTAINING PORT (301) AND THE REAR COVER SHEET (2) AND THE FRONT COVER SHEET (1) BEING FIXED.
Patent OA-12366-A (OA)
Title: Immunogenic HBc chimer particles having enhanced stability.
Inventor: BIRKETT ASHLEY J
IPC: C07K19/00
Filed: 2001-08-16
Abstract: A chimeric, carboxy-terminal truncated hepatitis B virus nucleocapsid protein (HBc) is disclosed that is engineered for both enhanced stability of self-assembled particles and the display of an immunogenic epitope. The display of the immunogenic epitope is displayed in the immunogenic loop of HBc, whereas the enhanced stability of self-assembled particles is obtained by the presence of at least one heterologous cysteine residue near the carboxy-terminus of the chimer molecule. Methods of making and using the chimers are also disclosed.
Patent RU-2002126260-A (RU)
IPC: B01J27/26
Filed: 2001-02-20
Abstract: A process for preparing polyether polyols includes a precipitation step, a recrystallization step, and a reaction step. In the precipitation step, a multimetal cyanide compound is precipitated by reaction of a metal salt with a cyanometalate compound. In the recrystallization step, the multimetal cyanide compound precipitated above is recrystallized by adding further metal salt and/or further cyanometalate compound. The recrystallization forms a multimetal cyanide catalyst compound. In the reaction step, an initiator and one or more alkylene oxide are reacted in the presence of the multimetal cyanide catalyst compound.
Patent RU-2004103473-A (RU)
IPC: B23B27/16
Filed: 2002-07-18
Abstract: A cutting tool comprising a holder and a cutting insert mounted therein. A second bore of the holder extends downwardly from an insert receiving pocket. A third bore extends rearwardly from the second bore and opens into a fourth bore. A locking pin inserted in the second bore protrudes upwardly into the first through bore. A protrusion extends rearwardly from an upper portion of the locking pin. A rearwardly facing groove in a lower portion of the locking pin is co-aligned with the third bore. A plunger is received in the third bore. A forward portion of the plunger is in contact engagement with the groove. A rear portion of the plunger has a first engagement surface transversely directed to a first axis (A) of the plunger. A clamping member, engaged in the fourth bore and having a second engagement surface, is in contact engagement with the first engagement surface.
Patent RU-2005141758-A (RU)
IPC: C09D7/80
Filed: 2004-06-10
Abstract: The present invention provides a color recipe calculation method for matt finished, solid color shades, by means of which it is possible to determine the proportion of matting agents in a color recipe in a manner decoupled from the actual calculation of the recipe and is based on a conventional spectrophotometric characterization of a matt sample using a standardised 45°/0° measurement geometry along with an established gloss measurement, or alternatively using a spectrophotometer equipped with a d/8° measurement geometry and analyzing readings taken with the specular component included and excluded.
Patent RU-2006140096-A (RU)
Title: Анти-il-13 антитела и комплексы
IPC: A61K39/395
Filed: 2005-06-09
Abstract: 1. Кристаллическое антитело, содержащее антитело против IL-13 или Fab фрагмент антитела против IL-13.2. Кристаллическое антитело по п.1, отличающееся тем, что имеет пространственную группу P222.3. Кристаллическое антитело по любому из п.1 или 2, отличающееся тем, что имеет следующие размеры элементарной ячейки: а=54.4, b=98.0 с=108.5, a α=β=γ=90°.4. Кристаллическое антитело по п.3, отличающееся тем, что оно представляет собой антитело млекопитающего, антитело человека, гуманизированное антитело, химерное антитело, антитело, полученное in vitro или моноклональное антитело.5. Кристаллическое антитело по п.4, отличающееся тем, что дополнительно содержит полипептид IL-13, связанный с указанным антителом.6. Кристаллическое антитело по п.5, отличающееся тем, что дополнительно содержит полипептид IL-13Rα1, связанный с полипептидом IL-13.7. Кристаллическое антитело по п.6, отличающееся тем, что содержит полипептид, включающий последовательность аминокислот SEQ ID NO:1 или SEQ ID NO:2.8. Кристаллическое антитело по п.7, отличающееся тем, что указанное антитело представляет собой mАb13.2 или Fab фрагмент mАb13.2.9. Кристаллическое антитело по п.8, отличающееся тем, что указанное антитело способно к связыванию с участком IL-13, который связывается с полипептидом IL-4R in vivo.10. Кристаллическое антитело по п.9, отличающееся тем, что указанное кристаллическое антитело рассеивает рентгеновское излучение с разрешением по меньшей мере примерно 3.5.11. Кристаллическое антитело по п.10, отличающееся тем, что указанное кристаллическое антитело имеет структурные координаты, указанные в таблице 10, +/- среднеквадратичное отклонение для альфа-атомов углерода не более, чем 1.5.12. Кристалличес�
Patent RU-2007106649-A (RU)
IPC: B60P1/44
Filed: 2005-08-10
Abstract: The loading platform unit (1) includes a platform (20) and lifting gear (10) with two horizontally spaced carrier arms (12, 14), a parallel cylinder (13) to turn the platform round the turning axis (19) from travel position to working position. A lifting cylinder (15) raises and lowers the platform. The platform is transversely spaced out from the carrier arms, and is able to turn on the second carrier arm.
Patent RU-2007136505-A (RU)
Title: Способ лечения острой ишемии конечностей
IPC: A61B17/00
Filed: 2007-10-02
Abstract: Способ лечения острой ишемии конечностей, при котором в зависимости от уровня поражения осуществляют операционный доступ к артериям, пережимают их и выключают из кровообращения магистральные артерии и коллатерали, производят вмешательство на артериях, а затем восстанавливают кровоток по артериям или когда реконструктивное оперативное вмешательство невозможно, отличающийся тем, что больному до оперативного вмешательства параллельно с введением препаратов, улучшающих микроциркуляцию тканей, внутривенно вводят перфторан в дозе 5 мл/кг массы тела и дают вдыхать воздушную смесь, обогащенную кислородом на 40-50% в течение 12 ч, во время оперативного вмешательства дополнительно вводят оксигенированный перфторан в артерии по 50 мл и после операции больному в течение 12 ч дают вдыхать указанную воздушную смесь, обогащенную кислородом с возможным последующим 10 дневным курсом гипербарической оксигенации.